• About Us
    • Company
    • Chairman's Message
    • Team
    • Our History
    • Corporate Culture
    • Honour
  • Technology
    • Research and Develop
    • Innovation Platform
    • Innovative Drugs
    • Research and Development Pipeline
  • Products
    • Digestive System
    • Cardiovascular System
    • Endocrine System
    • Nervous System
    • Inflammation
    • Respiratory System
  • News
    • Company News
    • Media Coverage
  • Investor Relations
    • Announcements and Circulars
    • Financial Reports
    • Prospectus
    • Corporate Governance
    • Contact IR
  • Careers
    • Talent Development
    • Recruitment Position
  • Contact Us
    • Contact Us
    • Product Consultation
  • 简 繁 En
  • 中文
  • 繁体
  • EN
  • About Us
  • Company
  • Chairman's Message
  • Team
  • Our History
  • Corporate Culture
  • Honour
  • Technology
  • Research and Develop
  • Innovation Platform
  • Innovative Drugs
  • Research and Development Pipeline
  • Products
  • Digestive System
  • Cardiovascular System
  • Endocrine System
  • Nervous System
  • Inflammation
  • Respiratory System
  • News
  • Company News
  • Media Coverage
  • Investor Relations
  • Announcements and Circulars
  • Financial Reports
  • Prospectus
  • Corporate Governance
  • Contact IR
  • Careers
  • Talent Development
  • Recruitment Position
  • Contact Us
  • Contact Us
  • Product Consultation
Company News

publish time: 2026-06-08

返回
About Us
Technology
Products
News
Investor Relations
Careers
Contact Us

Fujian Haixi New Pharmaceutical Creation Co., Ltd. Fujian ICP Record No. 12015727 Internet Drug Information Service Qualification Certificate No.: (Min) - Non-operating-2023-0063

Some of the text and pictures on this site are from the Internet and are only used for sharing and learning. If your rights and interests are infringed, please inform us in time, and this site will deal with or replace them in time.